Biogen execs outline setbacks, and potential gains, from COVID-19 pandemic

22nd April 2020 Uncategorised 0

Biogen may be the biopharma company whose employees have been most intimately affected by the COVID-19 pandemic. Aside from dozens of illnesses the drugmaker had to work through in recent months, its first-quarter numbers outline the many ways the pandemic can affect a drugmaker’s financial performance.

More: Biogen execs outline setbacks, and potential gains, from COVID-19 pandemic
Source: fierce